Intuitive Surgical (NASDAQ: ISRG) Q3 2024 Earnings Call Oct 17, 2024, 4:30 p.m. ET ...

ISRG's third-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement ...

We expect the company’s revenues to come in at $2 billion and adjusted earnings to be $1.60 per share, reflecting a top-line ...

Q3 2024 Earnings Call Transcript October 17, 2024 Intuitive Surgical, Inc. beats earnings expectations. Reported EPS is $1.84 ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Hold rating on Intuitive Surgical (ISRG – Research Report). The company’s shares closed yesterday at $473.73. Kalia covers ...

Intuitive Surgical, Inc. ISRG is set to report third-quarter 2024 earnings on Oct. 17. The Zacks Consensus Estimate for sales and earnings is pegged at $2.02 billion and $1.65 per share, respectively.

Intuitive Surgical, Inc. ISRG is set to report third-quarter 2024 earnings on Oct. 17. The Zacks Consensus Estimate for sales and earnings is pegged at $2.02 billion and $1.65 per share, respectively.

Intuitive Surgical is a global leader in minimally invasive surgical technologies, most renowned for its da Vinci Surgical System. This innovative system has transformed surgical procedures by ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Intuitive Surgical (ISRG – Research Report) today and set a price target of $525.00. The company’s shares closed yesterday at $473.73.

Medical devices maker Intuitive Surgical (ISRG) is scheduled to announce its third-quarter results on October 17. The company has exceeded analysts’ expectations for six consecutive quarters.